Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.22.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Three Months Ended
March 31,
Revenues: 2022 2021
Corporate clinics $ 12,606,999  $ 9,466,083 
Franchise operations 9,831,539  8,081,882 
Total revenues $ 22,438,538  $ 17,547,965 
Depreciation and amortization:
Corporate clinics 1,376,196  1,093,833 
Franchise operations 173,487  342 
Corporate administration 79,493  75,691 
Total depreciation and amortization $ 1,629,176  $ 1,169,866 
Segment operating (loss) income:
Corporate clinics $ (438,064) $ 1,349,057 
Franchise operations 4,403,238  3,847,773 
Total segment operating income $ 3,965,174  $ 5,196,830 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 3,965,174  $ 5,196,830 
Unallocated corporate (4,141,600) (3,225,154)
Consolidated (loss) income from operations (176,426) 1,971,676 
Other expense, net 16,147  21,537 
(Loss) income before income tax benefit $ (192,573) $ 1,950,139 
Reconciliation of Assets from Segment to Consolidated
Segment assets: March 31,
2022
December 31,
2021
Corporate clinics $ 41,328,616  $ 40,722,898 
Franchise operations 12,844,303 12,593,912
Total segment assets 54,172,919 53,316,810
Unallocated cash and cash equivalents and restricted cash 18,845,911 19,912,338
Unallocated property and equipment 807,832 857,176
Other unallocated assets 11,235,787 11,367,885
Total assets $ 85,062,449  $ 85,454,209